Is Fortress Biotech Stock a Good Investment?
Fortress Biotech Investment Advice | FBIO |
- Examine Fortress Biotech's financial health by looking at its balance sheet, income statement, and cash flow statement. Analyze key financial ratios, such as Price-to-Earnings (P/E), Price-to-Sales (P/S), and Price-to-Book (P/B), to determine whether the stock is fairly valued or over/undervalued.
- Research Fortress Biotech's leadership team and their track record. Good management can help Fortress Biotech navigate difficult times and make strategic decisions that benefit shareholders and increases its net worth.
- Consider the overall health of the Biotechnology space and any emerging trends that could impact Fortress Biotech's business and its evolving consumer preferences.
- Compare Fortress Biotech's performance and market position to its competitors. Analyze how Fortress Biotech is positioned in terms of product offerings, innovation, and market share.
- Check if Fortress Biotech pays a dividend and its dividend yield and payout ratio.
- Review what financial analysts are saying about Fortress Biotech's stock and their price targets. However, remember that analysts' opinions can vary, and their predictions may not always be accurate.
It's important to note that investing in Fortress Biotech stock, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember that it's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments. Below is a detailed guide on how to decide if Fortress Biotech is a good investment.
Sell | Buy |
Strong Sell
Market Performance | Insignificant | Details | |
Volatility | Dangerous | Details | |
Hype Condition | Stale | Details | |
Current Valuation | Overvalued | Details | |
Odds Of Distress | High | Details | |
Economic Sensitivity | Almost neglects market trends | Details | |
Investor Sentiment | Interested | Details | |
Analyst Consensus | Strong Buy | Details | |
Financial Leverage | Not Rated | Details | |
Reporting Quality (M-Score) | Unavailable | Details |
Examine Fortress Biotech Stock
Researching Fortress Biotech's stock involves analyzing various aspects of the company and its industry to make an informed investment decision. The key areas to focus on are fundamentals, business model and competitive advantage. It is also important to analyze trends in revenue, net income, and cash flow, as well as key financial ratios, such as price-to-earnings (P/E), price-to-sales (P/S), and debt-to-equity (D/E). About 21.0% of the company shares are held by company insiders. The book value of Fortress Biotech was currently reported as 0.79. The company recorded a loss per share of 27.73. Fortress Biotech had not issued any dividends in recent years. The entity had 1:15 split on the 10th of October 2023.
To determine if Fortress Biotech is a good investment, evaluating the company's potential for future growth is also very important. This may include expanding into new markets, launching new products or services, or improving operational efficiency. Companies with strong growth prospects can be more attractive investments. This aspect of the research should be conducted in the context of the overall market and industry in which the company operates and should include an analysis of growth potential, competitive landscape, and any regulatory or economic factors that could impact the business. Some of the essential points regarding Fortress Biotech's research are outlined below:
| Fortress Biotech had very high historical volatility over the last 90 days | |
| Fortress Biotech has high likelihood to experience some financial distress in the next 2 years | |
| The company reported the previous year's revenue of 84.51 M. Net Loss for the year was (60.64 M) with loss before overhead, payroll, taxes, and interest of (85.66 M). | |
| Fortress Biotech currently holds about 208.35 M in cash with (128.22 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.92. | |
| Roughly 21.0% of the company shares are held by company insiders | |
| Latest headline from thelincolnianonline.com: Fortress Biotech, Inc. Short Interest Up 1,700.0 percent in November |
Fortress Biotech Quarterly Long Term Debt |
|
Fortress Biotech uses earnings reports to provide investors with an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Therefore, it is also crucial when considering investing in Fortress Biotech. Every quarterly earnings report provides investors with an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Fortress Biotech's previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
| 4th of April 2024 Upcoming Quarterly Report | View | |
| 20th of May 2024 Next Financial Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 4th of April 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 31st of December 2022 Last Financial Announcement | View |
Earnings surprises can significantly impact Fortress Biotech's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate. Below are the table of largest EPS Surprises Fortress Biotech's investors have experienced.
| Reported | Fiscal Date | Estimated EPS | Reported EPS | Surprise | |||
|---|---|---|---|---|---|---|---|
2015-08-10 | 2015-06-30 | -0.14 | -0.12 | 0.02 | 14 | ||
2022-08-11 | 2022-06-30 | -0.21 | -0.24 | -0.03 | 14 | ||
2020-05-11 | 2020-03-31 | -0.23 | -0.19 | 0.04 | 17 | ||
2020-03-16 | 2019-12-31 | -0.31 | -0.27 | 0.04 | 12 | ||
2013-08-05 | 2013-06-30 | -0.34 | -0.38 | -0.04 | 11 | ||
2013-03-14 | 2012-12-31 | -0.28 | -0.32 | -0.04 | 14 | ||
2012-11-14 | 2012-09-30 | -0.28 | -0.24 | 0.04 | 14 | ||
2012-05-15 | 2012-03-31 | -0.31 | -0.35 | -0.04 | 12 |
Know Fortress Biotech's Top Institutional Investors
Have you ever been surprised when a price of an equity instrument such as Fortress Biotech is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Fortress Biotech backward and forwards among themselves. Fortress Biotech's institutional investor refers to the entity that pools money to purchase Fortress Biotech's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
| Shares | Renaissance Technologies Corp | 2024-09-30 | 78.1 K | Atria Investments Llc | 2024-09-30 | 71.5 K | 180 Wealth Advisors, Llc | 2024-09-30 | 68.3 K | Commonwealth Equity Services Inc | 2024-06-30 | 61.7 K | Hb Wealth Management, Llc | 2024-09-30 | 55.3 K | Integrated Wealth Concepts Llc | 2024-09-30 | 46.1 K | Northern Trust Corp | 2024-09-30 | 41.4 K | Titleist Asset Management, Llc | 2024-09-30 | 39 K | Rsm Us Wealth Management Llc | 2024-09-30 | 36.2 K | Vanguard Group Inc | 2024-09-30 | 625.1 K | Cambridge Invest Research Advisors, Inc. | 2024-09-30 | 554.4 K |
Fortress Biotech's market capitalization trends
The company currently falls under 'Micro-Cap' category with a current market capitalization of 46.86 M.Market Cap |
|
Fortress Biotech's profitablity analysis
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | (0.41) | (0.43) | |
| Return On Capital Employed | (1.72) | (1.81) | |
| Return On Assets | (0.36) | (0.38) | |
| Return On Equity | (2.69) | (2.82) |
Determining Fortress Biotech's profitability involves analyzing its financial statements and using various financial metrics to determine if Fortress Biotech is a good buy. For example, gross profit margin measures Fortress Biotech's profitability after accounting for the cost of goods sold, while net profit margin measures profitability after accounting for all expenses. Other important metrics include return on assets, return on equity, and free cash flow. By reviewing multiple sources and metrics, you can gain a complete picture of Fortress Biotech's profitability and make more informed investment decisions.
Evaluate Fortress Biotech's management efficiency
Fortress Biotech has return on total asset (ROA) of (0.3641) % which means that it has lost $0.3641 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (17.3964) %, meaning that it created substantial loss on money invested by shareholders. Fortress Biotech's management efficiency ratios could be used to measure how well Fortress Biotech manages its routine affairs as well as how well it operates its assets and liabilities. As of the 2nd of December 2024, Return On Tangible Assets is likely to drop to -0.43. In addition to that, Return On Capital Employed is likely to drop to -1.81. At this time, Fortress Biotech's Total Assets are very stable compared to the past year. As of the 2nd of December 2024, Total Current Assets is likely to grow to about 156.5 M, while Other Assets are likely to drop about 3.7 M.| Last Reported | Projected for Next Year | ||
| Book Value Per Share | 0.20 | 0.19 | |
| Tangible Book Value Per Share | (2.31) | (2.19) | |
| Enterprise Value Over EBITDA | (0.24) | (0.25) | |
| Price Book Value Ratio | 1.08 | 1.03 | |
| Enterprise Value Multiple | (0.24) | (0.25) | |
| Price Fair Value | 1.08 | 1.03 | |
| Enterprise Value | 32.1 M | 53.6 M |
The operational strategies employed by Fortress Biotech management play a crucial role in its market positioning. Assessing these strategies alongside financial data helps us evaluate the stock's investment potential.
Beta 1.746 |
Basic technical analysis of Fortress Stock
As of the 2nd of December, Fortress Biotech shows the Downside Deviation of 4.84, coefficient of variation of 2649.35, and Mean Deviation of 3.43. Fortress Biotech technical analysis allows you to utilize historical prices and volume patterns in order to determine a pattern that computes the direction of the firm's future prices.Fortress Biotech's insider trading activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Fortress Biotech insiders, such as employees or executives, is commonly permitted as long as it does not rely on Fortress Biotech's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Fortress Biotech insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Fortress Biotech's Outstanding Corporate Bonds
Fortress Biotech issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Fortress Biotech uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Fortress bonds can be classified according to their maturity, which is the date when Fortress Biotech has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| FORTUNE BRANDS HOME Corp BondUS34964CAA45 | View | |
| US34964CAE66 Corp BondUS34964CAE66 | View | |
| FBINUS 45 25 MAR 52 Corp BondUS34964CAG15 | View | |
| FBINUS 4 25 MAR 32 Corp BondUS34964CAF32 | View | |
| US34960PAD33 Corp BondUS34960PAD33 | View | |
| BNP Paribas FRN Corp BondUSF1R15XK367 | View | |
| FORTUNE BRANDS INC Corp BondUS349631AG67 | View |
Understand Fortress Biotech's technical and predictive indicators
Using predictive indicators to make investment decisions involves analyzing Fortress Biotech's various financial and market-based factors to help forecast future trends and identify investment opportunities. Select the indicators that are most relevant to your investment strategy. Each indicator has its own strengths and weaknesses, so it's essential to combine multiple indicators to get a more comprehensive view of the market and reduce the risk of making poor decisions based on limited data.
| Risk Adjusted Performance | 0.0373 | |||
| Market Risk Adjusted Performance | 0.12 | |||
| Mean Deviation | 3.43 | |||
| Semi Deviation | 4.41 | |||
| Downside Deviation | 4.84 | |||
| Coefficient Of Variation | 2649.35 | |||
| Standard Deviation | 4.92 | |||
| Variance | 24.21 | |||
| Information Ratio | 0.0098 | |||
| Jensen Alpha | (0.03) | |||
| Total Risk Alpha | (0.65) | |||
| Sortino Ratio | 0.0099 | |||
| Treynor Ratio | 0.11 | |||
| Maximum Drawdown | 26.13 | |||
| Value At Risk | (5.08) | |||
| Potential Upside | 9.19 | |||
| Downside Variance | 23.43 | |||
| Semi Variance | 19.44 | |||
| Expected Short fall | (4.22) | |||
| Skewness | (0.11) | |||
| Kurtosis | 3.77 |
| Risk Adjusted Performance | 0.0373 | |||
| Market Risk Adjusted Performance | 0.12 | |||
| Mean Deviation | 3.43 | |||
| Semi Deviation | 4.41 | |||
| Downside Deviation | 4.84 | |||
| Coefficient Of Variation | 2649.35 | |||
| Standard Deviation | 4.92 | |||
| Variance | 24.21 | |||
| Information Ratio | 0.0098 | |||
| Jensen Alpha | (0.03) | |||
| Total Risk Alpha | (0.65) | |||
| Sortino Ratio | 0.0099 | |||
| Treynor Ratio | 0.11 | |||
| Maximum Drawdown | 26.13 | |||
| Value At Risk | (5.08) | |||
| Potential Upside | 9.19 | |||
| Downside Variance | 23.43 | |||
| Semi Variance | 19.44 | |||
| Expected Short fall | (4.22) | |||
| Skewness | (0.11) | |||
| Kurtosis | 3.77 |
Consider Fortress Biotech's intraday indicators
Fortress Biotech intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Fortress Biotech stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
Fortress Biotech Corporate Filings
F3 | 15th of November 2024 An amendment to the original Schedule 13D filing | ViewVerify |
8K | 14th of November 2024 Report filed with the SEC to announce major events that shareholders should know about | ViewVerify |
13A | 25th of October 2024 The form used by investors holding more than 5% of a company's stock, to report their beneficial ownership pursuant to Rule 13d-1 or Rule 13d-2 under the Securities Exchange Act of 1934 | ViewVerify |
| 7th of October 2024 Other Reports | ViewVerify |
Fortress Stock media impact
Far too much social signal, news, headlines, and media speculation about Fortress Biotech that are available to investors today. That information is available publicly through Fortress media outlets and privately through word of mouth or via Fortress internal channels. However, regardless of the origin, that massive amount of Fortress data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Fortress Biotech news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Fortress Biotech relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Fortress Biotech's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Fortress Biotech alpha.
Fortress Biotech Sentiment by Major News Outlets
Investor sentiment, mood or attitude towards Fortress Biotech can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
Fortress Biotech Corporate Management
| George Avgerinos | Sr. VP of Biologics Operations | Profile | |
| Samuel Berry | General Secretary | Profile | |
| Robyn Hunter | Ex Officer | Profile | |
| Thomas Schaible | Project Disease | Profile |
Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Fortress Biotech. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product. To learn how to invest in Fortress Stock, please use our How to Invest in Fortress Biotech guide.You can also try the Instant Ratings module to determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Fortress Biotech. If investors know Fortress will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Fortress Biotech listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (27.73) | Revenue Per Share 6.15 | Quarterly Revenue Growth (0.14) | Return On Assets (0.36) | Return On Equity (17.40) |
The market value of Fortress Biotech is measured differently than its book value, which is the value of Fortress that is recorded on the company's balance sheet. Investors also form their own opinion of Fortress Biotech's value that differs from its market value or its book value, called intrinsic value, which is Fortress Biotech's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Fortress Biotech's market value can be influenced by many factors that don't directly affect Fortress Biotech's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
In summary, please note that there is a difference between Fortress Biotech's value and its price, as these two are different measures arrived at by various means. Investors typically determine if Fortress Biotech is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Fortress Biotech's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.